Uterine fibroids are a common gynaecological condition, and because conservative surgery can only remove visible lesions, recurrence rates after the procedure remain high. This systematic review and meta-analysis investigated whether Chinese herbal medicine could reduce the likelihood of fibroids returning following surgery, drawing on randomised controlled trials published up to March 2025 and identified across eight major international and Chinese databases.
Sixteen trials involving a total of 1,627 patients were included. The analysis found that Chinese herbal medicine significantly reduced postoperative recurrence rates compared with no treatment, with conventional western medicine alone, and when combined with conventional western medicine. Beyond recurrence prevention, Chinese herbal medicine also demonstrated benefits in improving overall clinical effectiveness, restoring serum sex hormone levels to a healthier balance, lowering plasma viscosity, and supporting the return of the uterus to its normal volume after surgery. The safety profile was generally favourable, with a low rate of adverse reactions reported across the included studies.
The authors acknowledge notable limitations: the number of included trials is relatively small, and the overall quality of evidence is preliminary. They caution that the findings require validation through larger, higher-quality randomised controlled trials before firm clinical recommendations can be made.
Conclusion: This meta-analysis provides encouraging evidence that Chinese herbal medicine may meaningfully reduce uterine fibroid recurrence after conservative surgery and support recovery, though further rigorous research is needed to confirm these findings.
Source: Liu Z, Liu Y, Li S and colleagues. Journal of ethnopharmacology (2027). View on PubMed (PMID 42962945) · doi:10.1016/j.jep.2026.121203
Acupuncture Times Your guide to acupuncture, Chinese herbal medicine and TCM — explore acupoints, herbs and formulas, plus the latest acupuncture research news.